vTv reports 2023 fourth quarter and full-year financial results and recent corporate developments.

Read the full release here:
tinyurl.com/56b7w5d3

We are thrilled to announce the FDA submission for our first Phase 3 trial evaluating the safety and efficacy of our lead candidate, cadisegliatin, in adults diagnosed with #T1D !

For more details, read the full release here: tinyurl.com/y6ad4avm

vTv will present at TD Cowen’s 44th Annual Healthcare Conference, on March 4-6, 2024, in Boston, MA. Tune in for the live webcast of the presentation tomorrow, Tuesday, March 5th, at 9:50 AM ET, here: ir.vtvtherapeutics.com/events.

Full release here: tinyurl.com/mw54su9n

vTv announces a $51 Million Private Placement with leading, healthcare-focused institutional investors and the JDRF T1D Fund, which will fund the first p3 study of cadisegliatin as an adjunctive therapy to insulin.

Full release here: tinyurl.com/2pa7cxx4

#ICYMI : Dr. Thomas Strack, accomplished pharmaceutical R&D executive, was recently appointed Chief Medical Officer of vTv!

We are thrilled to welcome him to the team!

Read the full release here: tinyurl.com/3ub66kwd

Congratulations to our partner #CantexPharmaceuticals , Inc. on their recent accomplishments for initiating studies utilizing #azeliragon (a novel antagonist of RAGE)!

For more details on the studies and partnerships, read the full news releases here: cantex.com/latest-news/

vTv reports second quarter 2023 financial results and recent corporate highlights.

Read the full release here:
tinyurl.com/53nk8pzy

Exciting news! Our partner Cantex Pharmaceuticals announced a publication in NPJ Breast Cancer highlighting the potential role of RAGE inhibition to prevent metastasis in #TNBC npj Journals

Read the full news release here: tinyurl.com/4xer4fwh

Join JDRF on Tuesday, June 27 at 6 pm to learn top research advances in #T1D with JDRF Chief Scientific Officer Dr. Sanjoy Dutta!

You won’t want to miss it! Register here: tinyurl.com/SanjoyDutta

#DYK : Stress can increase your blood sugar levels.

Managing #diabetes can be stressful. Therefore, it’s important to find healthy ways to cope with stress.

Watch this video from CDC to learn some tips: tinyurl.com/3un3zmef

Great news! Our partner #CantexPharmaceuticals received a #patent for the use of #azeliragon as a treatment of #glioblastoma !

Read the full news release here: tinyurl.com/373enbpk

Regular blood sugar monitoring is the most important thing you can do to manage #T1D or #T2D .

Monitoring can help you understand how certain foods, medicines, and physical activity can affect your numbers.

To learn more visit: tinyurl.com/y44tjza3

CDC Diabetes

#DYK : There are over 100 actively recruiting studies for #T1D in the U.S.

#Clinicaltrials are essential for delivering treatments to T1D patients.

Learn how you can make an important contribution to the advancement of medicine here:
tinyurl.com/2jkexva6
JDRF

Are you at risk for Type 1 diabetes?

#T1D doesn’t discriminate. It affects people of all ages and backgrounds.

Researchers have uncovered T1D risk factors that increase a person’s likelihood of developing the disease.

Learn more here:
tinyurl.com/mutj2mfy
JDRF

#ICYMI : vTv recently reported fourth quarter financial results and corporate highlights.

Read the full release here: tinyurl.com/y8aaatbc

#DYK : Nearly 1 in 3 adults may have #CKD . CKD is a condition where the kidneys are damaged and cannot filter blood as well as they should. Excess fluid and waste from blood remain in the body and may cause health problems.

Learn more from CDC, here:

tinyurl.com/4tfwrraw

Is your child managing #T1D at school? No two kids handle their diabetes the same way, so it’s important to inform staff about how to best support your child’s needs.

Learn how to create a diabetes management plan to keep your child healthy: CDC

cdc.gov/diabetes/libra…

Becoming sick is never enjoyable but having #T1D can make it more difficult and can pose a serious risk for patients. Therefore, it’s critical to have a plan of action in place.

To learn some tips from JDRF on how to navigate #T1D and the flu, visit:

tinyurl.com/2s3szvtd

Tune in on Tues., Feb. 21st at 11:00 AM EST for an #AskTheEndo virtual session hosted by JDRF, with pediatric endocrinologist Dr. Saleh Adi.

Bring your #T1D management and #endo questions and meet others in the T1D community!

Register here: tinyurl.com/mr3kve5e